As of Jun 05
| -0.03 / -3.00%|
The 1 analysts offering 12-month price forecasts for Evofem Biosciences Inc have a median target of 225.00, with a high estimate of 225.00 and a low estimate of 225.00. The median estimate represents a +23,095.88% increase from the last price of 0.97.
The current consensus among 1 polled investment analysts is to Buy stock in Evofem Biosciences Inc. This rating has held steady since November, when it was unchanged from a Move your mouse over past
months for detail
Move your mouse over a quarter or year to see how estimates have changed over time.